Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (DRKS00038002) titled 'Identifying Neuro-cognitive-physiological Factors that Moderate Anxiety and Depression' on Sept. 30.
Study Type: observational
Study Design:
Allocation:
Masking:
Control:
Assignment:
Study design purpose: diagnostic
Primary Sponsor: Max Planck Institute for Human Cognitive and Brain Sciences, Department of Neurology
Condition:
F32.0, F32.1, F32.2, F32.8, F32.9, F33.0, F33.1 F33.2 , F33.8, F33.9, F34.1, F40.0, F40.1, F40.2, F40.8, F40.9, F41.0, F41.1, F41.2, F41.3, F41.8, F41.9
Intervention:
Group 1: Individuals diagnosed with anxiety and/or depression disorders, undergoing task-based and resting-state fMRI, E...